• 1
    Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993–1994. Pediatrics 2000;105: 12161226.
  • 2
    Horbar JD, Stillman AL. Vermont Oxford Network Annual Database Summary for 2000. Burlington : Vermont Oxford Network, 2002.
  • 3
    Volpe JJ. Neurology of the Newborn, 3rd edition. Philadelphia : W.B. Saunders, 1995.
  • 4
    Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol 1998;5: 135151.
  • 5
    Cooke RW. Trends in incidence of cranial ultrasound lesions and cerebral palsy in very low birthweight infants 1982–93. Arch Dis Child Fetal Neonatal Ed 1999;80: F115F117.
  • 6
    Battin M, Ling EW, Whitfield MF, Mackinnon M, Effer SB. Has the outcome for extremely low gestational age (ELGA) infants improved following recent advances in neonatal intensive care?. Am J Perinatol 1998;15: 469477.
  • 7
    Murphy BP, Inder TE, Rooks V, et al. Posthaemorrhagic ventricular dilatation in the premature infant: natural history and predictors of outcome. Arch Dis Child Fetal Neonatal Ed 2002;87: F37F41.
  • 8
    Wiswell TE, Robertson CF, Jones TA, Tuttle DJ. Necrotizing enterocolitis in full-term infants. A case-control study. Am J Dis Child 1988;142: 532535.
  • 9
    Crissinger KD. Necrotizing enterocolitis, epidemiologic, clinical, and pathologic features. In: FanaroffAA, MartinRJ editors. Neonatal-Perinatal Medicine, 6th edition. Diseases of the Fetus and Infant, 2. St Louis : Mosby, 1997: 13331334.
  • 10
    Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33: 179201.
  • 11
    Stoll BJ. Epidemiology of necrotizing enterocolitis. Clin Perinatol 1994;21: 205218.
  • 12
    The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Investigators of the Vermont-Oxford Trials Network Database Project. Pediatrics 1993;91: 540545.
  • 13
    Caplan MS, MacKendrick W. Inflammatory mediators and intestinal injury. Clin Perinatol 1994;21: 235246.
  • 14
    Ricketts RR. Surgical treatment of necrotizing enterocolitis and the short bowel syndrome. Clin Perinatol 1994;21: 365387.
  • 15
    Grosfeld JL, Cheu H, Schlatter M, West KW, Rescorla FJ. Changing trends in necrotizing enterocolitis. Experience with 302 cases in two decades. Ann Surg 1991;214: 300306; discussion 306–307.
  • 16
    Grosfeld JL, Rescorla FJ, West KW. Short bowel syndrome in infancy and childhood. Analysis of survival in 60 patients. Am J Surg 1986;151: 4146.
  • 17
    Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990;97: 1125.
  • 18
    Suresh GK, Soll RF. Current surfactant use in premature infants. Clin Perinatol 2001;28: 671694.
  • 19
    Northway WH, Jr Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276: 357368.
  • 20
    Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr Clin North Am 1994;41: 277315.
  • 21
    Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999;46: 641643.
  • 22
    Albertine KH, Jones GP, Starcher BC, et al. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 1999;159: 945958.
  • 23
    Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82: 527532.
  • 24
    Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163: 17231729.
  • 25
    Northway WH, Jr Moss RB, Carlisle KB, et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990;323: 17931799.
  • 26
    Gross SJ, Iannuzzi DM, Kveselis DA, Anbar RD. Effect of preterm birth on pulmonary function at school age: a prospective controlled study. J Pediatr 1998;133: 188192.
  • 27
    Blayney M, Kerem E, Whyte H, O'Brodovich H. Bronchopulmonary dysplasia: improvement in lung function between 7 and 10 years of age. J Pediatr 1991;118: 201206.
  • 28
    Gerstmann DR, Wood K, Miller A, et al. Childhood outcome after early high-frequency oscillatory ventilation for neonatal respiratory distress syndrome. Pediatrics 2001;108: 617623.
  • 29
    Wheatley CM, Dickinson JL, Mackey DA, Craig JE, Sale MM. Retinopathy of prematurity: recent advances in our understanding. Br J Ophthalmol 2002;86: 696700.
  • 30
    Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol 2001;119: 11101118.
  • 31
    Pearce IA, Pennie FC, Gannon LM, Weindling AM, Clark DI. Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser. Br J Ophthalmol 1998;82: 12541259.
  • 32
    Connolly BP, McNamara JA, Sharma S, Regillo CD, Tasman W. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity. Ophthalmology 1998;105: 16281631.
  • 33
    Ng EY, Connolly BP, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: Part 1. Visual function and structural outcome. Ophthalmology 2002;109: 928934.
  • 34
    Connolly BP, Ng EY, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: Part 2. Refractive outcome. Ophthalmology 2002;109: 936941.
  • 35
    O'Shea TM, Klinepeter KL, Goldstein DJ, Jackson BW, Dillard RG. Survival and developmental disability in infants with birth weights of 501 to 800 grams, born between 1979 and 1994. Pediatrics 1997;100: 982986.
  • 36
    Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001;344: 95101.
  • 37
    The Victorian Infant Collaborative Study GroupImproved outcome into the 1990s for infants weighing 500–999 g at birth. Arch Dis Child Fetal Neonatal Ed 1997;77: F91F94.